PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 17, 2026Drugs in Context1 citationsOpen Access

Efficacy and safety of Serenoa repens in benign prostatic disorders: a systematic review of recent clinical evidence

ISI. SchwartzmannARAnna RedondoAFAlba Farré

Key Points

  • This review aims to assess the recent clinical evidence regarding the efficacy and safety of Serenoa repens for treating benign prostatic disorders.
  • Comprehensive systematic review of literature from the past 5 years
  • Includes studies on Serenoa repens used as monotherapy and in combination with other treatments
  • Evidence suggests that Serenoa repens may be effective in reducing symptoms associated with benign prostatic disorders.
  • Safety profile indicates it is well-tolerated with minimal adverse effects.

Abstract

This systematic review comprehensively evaluates literature from the past 5 years on the efficacy and safety of Serenoa repens in the treatment of benign prostatic disorders, either as monotherapy or in combination with other treatments.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Schwartzmann et al. (2026) studied this question.

synapsesocial.com/papers/6a095a427880e6d24efe0640https://doi.org/10.7573/dic.2025-10-2
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pharmacology, efficacy and safety of different extracts of Serenoa repens in patients with lower urinary tract symptoms and benign prostatic hyperplasia: a narrative review2026
  2. 2Effects of long term treatment with serenoa repens on the concentrations and regional distribution of androgen and epidermal growth factor in benign prostatic hyperplasia1998
  3. 3Efficacy of Serenoa repens lipido-sterolic extract alone or in combination with propolis polyphenols and Boswellia serrata extract suppositories on PSA level and symptoms in patients affected by lower urinary tract disorders2025 · 1 citations
  4. 4Efficacy and safety of α-blockers plus 5α-reductase inhibitors for benign prostatic hyperplasia: a systematic review and meta-analysis2026
  5. 5Exploring the use of phytotherapy in benign prostatic hyperplasia [BPH]: a systematic review2026 · 1 citations